|Grant Affiliation:||Ciaramella: mRNA Encoded Abs for HIV Prophylaxis|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2016-05-26|
|Study Made Public:||2020-06-05|
Neutralizing activity of mRNA derived bnAbs
CAVD 568 is a monoclonal antibody study evaluating HIV bnAbs expressed from various constructs.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.